Abstract

To prospectively compare gadoxetate disodium-enhanced magnetic resonance (MR) imaging with multiphasic 64-section multidetector computed tomography (CT) in the detection of hepatocellular carcinoma (HCC) in patients with cirrhosis. Institutional review board approval and informed patient consent were obtained for this prospective study. Fifty-eight patients (39 men, 19 women; mean age, 63 years; age range, 35-84 years) underwent gadoxetate disodium-enhanced MR imaging and multiphasic 64-section multidetector CT. The imaging examinations were performed within 30 days of each other. The two sets of images were qualitatively analyzed in random order by three independent readers in a blinded and retrospective fashion. Using strict diagnostic criteria for HCC, readers classified all detected lesions with use of a four-point confidence scale. The reference standard was a combination of pathologic proof, conclusive imaging findings, and substantial tumor growth at follow-up CT or MR imaging (range of follow-up, 90-370 days). The diagnostic accuracy, sensitivity, and positive predictive value were compared between the two image sets. Interreader variability was assessed. The accuracy of each imaging method was determined by using an adjusted modified chi(2) test. Eighty-seven HCCs (mean size +/- standard deviation, 1.8 cm +/- 1.5; range, 0.3-7.0 cm) were confirmed in 42 of the 58 patients. Regardless of lesion size, the average diagnostic accuracy and sensitivity for all readers were significantly greater with gadoxetate disodium-enhanced MR imaging (average diagnostic accuracy: 0.88, 95% confidence interval [CI]: 0.80, 0.97; average sensitivity: 0.85, 95% CI: 0.74, 0.96) than with multidetector CT (average diagnostic accuracy: 0.74, 95% CI: 0.65, 0.82; average sensitivity: 0.69, 95% CI: 0.59, 0.79) (P < .001 for each). No significant difference in positive predictive value was observed between the two image sets for each reader. Interreader agreement was good to excellent. Compared with multiphasic 64-section multidetector CT, gadoxetate disodium-enhanced MR imaging yields significantly higher diagnostic accuracy and sensitivity in the detection of HCC in patients with cirrhosis.

Highlights

  • Michele Di Martino, MD Daniele Marin, MD2 Antonino Guerrisi, MD Mahbubeh Baski, MD Francesca Galati, MD Massimo Rossi, MD Stefania Brozzetti, MD Raffaele Masciangelo, MD Roberto Passariello, MD Carlo Catalano, MD

  • Regardless of lesion size, the average diagnostic accuracy and sensitivity for all readers were significantly greater with gadoxetate disodium–enhanced magnetic resonance (MR) imaging than with multidetector computed tomography (CT) (P, .001 for each)

  • For all hepatocellular carcinoma (HCC) lesions and for lesions 2 cm or smaller, the diagnostic accuracy across the three readers was significantly greater with gadoxetate disodium– enhanced MR imaging than with multidetector CT (0.88 [95% confidence intervals (CIs): 0.80, 0.97] vs 0.74 [95% CI: 0.65, 0.82], respectively, for all lesions and 0.84 [95% CI: 0.73, 0.95] vs 0.67 [95% CI: 0.56, 0.79] for lesions Յ2 cm; P, .001) (Table 5)

Read more

Summary

Objectives

The purpose of this study was to prospectively compare gadoxetate disodium–enhanced MR imaging with multiphasic 64-section multidetector CT in the detection of HCC in patients with cirrhosis

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call